Impact of COVID-19 on inpatient referral of acute heart failure: a single-centre experience from the south-west of the UK.
Gemina DoolubChih WongLynsey HewitsonAhmed MohamedFraser ToddLaisha GogolaAndrew Skyrme-JonesShahid AzizEva SammutAmardeep DastidarPublished in: ESC heart failure (2021)
There was a reduction in referral of patients with acute heart failure with significant increase in mortality in the 8 weeks following the first reported UK death due to COVID-19. The observation of increased mortality does not appear related to a change in population in terms of demographics, left ventricular ejection fraction, or N-terminal pro-brain natriuretic peptide. The observed increased mortality appears to be related to the coexistence of COVID19 infection with acute heart failure. The study highlights the need for widespread preventative and shielding measures particularly in this group of patients especially in the light of the second wave. Longer follow-up with inclusion of data from other centres and community heart failure services will be needed.
Keyphrases
- acute heart failure
- heart failure
- ejection fraction
- aortic stenosis
- left ventricular
- coronavirus disease
- cardiovascular events
- sars cov
- primary care
- mental health
- healthcare
- cardiac resynchronization therapy
- risk factors
- newly diagnosed
- end stage renal disease
- acute myocardial infarction
- type diabetes
- atrial fibrillation
- hypertrophic cardiomyopathy
- resting state
- palliative care
- acute coronary syndrome
- functional connectivity
- electronic health record
- transcatheter aortic valve replacement
- coronary artery disease
- anti inflammatory
- respiratory syndrome coronavirus
- aortic valve
- patient reported outcomes
- data analysis
- mitral valve
- drug induced